Breakthrough for Dogs with Heart Disease: First FDA-Approved Liquid Treatment for Congestive Heart Failure

Boehringer Ingelheim has unveiled VETMEDIN® Solution, the first FDA-approved oral liquid treatment for managing CHF in dogs caused by MMVD or DCM. This new option offers a convenient and precise way to support canine heart health, especially for dogs that may struggle with tablets. Previous studies have demonstrated VETMEDIN®'s ability to enhance survival time and quality of life in dogs with these conditions.